Finance

Lists
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
4,03 US$
-1,95%
(-0,080) 1D
12 ოქტ, 15:50:14 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
4,20 US$
High
4,20 US$
Low
4,00 US$
Mkt. cap
69,23 მლნ.
Avg. vol.
59,95 ათ.
Volume
39,08 ათ.
52-wk high
9,82 US$
52-wk low
3,28 US$
EPS
-1,67 US$
Beta
1,60
Shares outstanding
17,18 მლნ.
No. of employees
76
Open
4,20 US$
High
4,20 US$
Low
4,00 US$
Mkt. cap
69,23 მლნ.
Avg. vol.
59,95 ათ.
Volume
39,08 ათ.
52-wk high
9,82 US$
52-wk low
3,28 US$
EPS
-1,67 US$
Beta
1,60
Shares outstanding
17,18 მლნ.
No. of employees
76
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees76
Founded2013
HeadquartersWest Chester, პენსილვანია, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current 4,03 US$
20,00 US$ (+396,28%)
Average
13,67 US$ (+239,21%)
Lowest
9,00 US$ (+123,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
9,00 US$
+123,3%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
12,00 US$
+197,8%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
20,00 US$
+396,3%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
17,00 US$
+321,8%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
14,34 მლნ.
5,09 მლნ.
5,02 მლნ.
5,86 მლნ.
Cost of goods sold
3,31 მლნ.
3,92 მლნ.
4,75 მლნ.
6,91 მლნ.
Cost of revenue
3,31 მლნ.
3,92 მლნ.
4,75 მლნ.
6,91 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,40 მლნ.
8,12 მლნ.
9,99 მლნ.
10,35 მლნ.
Operating expense
9,40 მლნ.
8,12 მლნ.
9,99 მლნ.
10,35 მლნ.
Total operating expenses
12,72 მლნ.
12,04 მლნ.
14,74 მლნ.
17,26 მლნ.
Operating income
1,63 მლნ.
-6,95 მლნ.
-9,72 მლნ.
-11,40 მლნ.
Other non operating income
34,00 ათ.
1,76 მლნ.
-8,00 ათ.
-3,00 ათ.
EBT including unusual items
-274,00 ათ.
-8,07 მლნ.
-9,68 მლნ.
-13,15 მლნ.
EBT excluding unusual items
-274,00 ათ.
-6,30 მლნ.
-9,68 მლნ.
-11,46 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-274,00 ათ.
-8,07 მლნ.
-9,68 მლნ.
-13,15 მლნ.
Net profit margin
-1,91%
-158,56%
-192,75%
-224,38%
Earnings per share
0,13
-0,51
-0,45
-0,48
Interest and investment income
159,00 ათ.
205,00 ათ.
201,00 ათ.
111,00 ათ.
Interest expense
-2,09 მლნ.
-1,31 მლნ.
-160,00 ათ.
-164,00 ათ.
Net interest expenses
-1,94 მლნ.
-1,11 მლნ.
41,00 ათ.
-53,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,74 მლნ.
-6,83 მლნ.
-9,60 მლნ.
-11,27 მლნ.
Gain or loss from assets sale
68,00 ათ.
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები